Caption Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-20,000
Closed -$1.83M 1531
2021
Q2
$1.83M Sell
20,000
-17,500
-47% -$1.39M 0.02% 708
2021
Q1
$2.55M Buy
+37,500
New +$2.91M 0.05% 443
2020
Q2
Sell
-17,800
Closed -$388K 956
2020
Q1
$388K Buy
+17,800
New +$399K 0.02% 591
2019
Q4
Sell
-55,000
Closed -$1.24M 839
2019
Q3
$1.24M Buy
+55,000
New +$1.52M 0.06% 339

Other funds holding CDNA

Caption Management's CDNA Position: Q3 2021 in Review

Caption Management sold out of CareDx (CDNA) in Q3 2021, closing a stake of 20,000 shares — an estimated $1.83M sold.

Caption Management first reported a position in CDNA in Q3 2019 and held it in 4 quarters. The position peaked at $2.55M in Q1 2021. 260 funds tracked by Wall St. Rank hold CDNA as of Q3 2021.

  • Caption Management reported no remaining CareDx position as of Q3 2021 after selling out during the quarter.
  • Caption Management sold 20,000 CareDx shares in Q3 2021, an estimated $1.83M.
  • Caption Management first reported a position in CareDx in Q3 2019 and held it in 4 quarters.
  • Caption Management's CareDx position peaked at $2.55M in Q1 2021.
  • 260 funds tracked by Wall St. Rank held CareDx as of Q3 2021.

Based on Caption Management's 13F filing for Q3 2021, filed 12 Nov 2021.